Veeva APAC Summit

Transforming clinical trials: Unveiling a connected ecosystem for enhanced efficiency and accessibility

In anticipation of the upcoming Veeva APAC Summit on September 4th at ICC Sydney, Eunho Shin, Vice President of Vault R&D Strategy Asia, at Veeva Systems offers an exclusive sneak peek into the evolving landscape of clinical trials.

Reflecting on the monumental impact of COVID-19, Mr Shin highlights the significant shifts in the clinical trial landscape locally in Australia and across the broader Asia Pacific. These changes are reshaping how clinical trials are conducted, managed and accelerated.

Australia’s substantial annual investment of $1.4 billion in industry-sponsored clinical trials is a cornerstone of its economy. However, challenges stemming from the fragmented and siloed ecosystem emphasises the need to streamline operations for more efficient outcomes. Veeva Systems’ versatility in catering to diverse organisations is a key focus of the discussion. From large multinationals to SMEs and hospital networks, Veeva offers tailored solutions to meet unique customer needs, streamlining the clinical trial process with technology.

Considering Australia’s National One Stop Shop consultation report, Mr Shin also discusses how Veeva’s R&D solutions will seek to align with the new approach proposed in the framework, offering insights into potential synergies.

In essence, this interview provides an exploration of the R&D landscape and Veeva Systems’ contributions to reshaping clinical trials and advancing healthcare in Australia and across the Asia Pacific region.